Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Lung Perfusion (IVLP) as an Adjuvant Treatment for Patients With Resectable Pulmonary Metastases of Colorectal Cancers

NCT05611034 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05611034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05611034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Lung Perfusion (IVLP) as an Adjuvant Treatment for Patients With Resectable Pulmonary Metastases of Colorectal Cancers
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Recruiting
Start date
February 6, 2023
Completion date
January 1, 2032
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, colorectal cancer metastatic, lung metastases